Lexicon Pharmaceuticals, INC 8-K filings
NASDAQ
8-K: Lexicon Pharmaceuticals Secures $250 Million in Oversubscribed Private Placement to Fuel Growth
Lexicon Pharmaceuticals has successfully raised $250 million through a private placement of convertible preferred stock to support its research, development, and commercialization efforts.